Abstract
Heart transplantation is the clinically acceptable treatment for end-stage heart failure. Since the development of better immunosuppressive regimes and particularly the introduction of Cyclosporin A in 1983, which combats cellular rejection, short-term survival for heart transplant recipients has increased steadily with survival at 1 year being in the order of 85% (Kriett and Kaye 1990). The major medium to long-term complication is development of a proliferative occlusive disease of the vasculature of the allograft. This disease, variously described as transplant associated coronary artery disease (TxCAD; Rose and Dunn 1993), cardiac allograft vasculopathy (CAV; Hosenpud et al. 1992), accelerated coronary artery sclerosis (ACS; Yacoub and Rose, 1994) and graft coronary artery sclerosis (GCA; Schoen and Libby 1991), is a rapidly progressing disease which causes blockage of the coronary arteries. The incidence of TxCAD varies between heart transplant centres. Harefield Hospital, U.K. has an incidence of 6% at 1 year increasing to 17% at 3 years (see Dunn and Rose, 1993), however, other centres have reported incidences as high as 10%–20% at 1 year, 25%–40% at 3 years and at least 40%–50% at 5 years (Gao et al. 1989; Uretsky et al. 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birkholz S, Goroncy-Bermes P, Schonerkark M, Hansch GM, Opferkuch W (1990) Intermediate filaments vimentin and desmin share epitopes with M1 protein of group A Streptococci. Zentralbl Bakt 274: 183–194
Castellot JJ Jr, Wright TC, Karnovsky MJ (1987) Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates. Semin Thromb Haemost 13: 489–503
Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J (1985) The vascular endothelial cell antigen system. Transplantation 39: 286–289
Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after arterial injury. Lab Invest 49: 208–215
Clowes AW, Clowes MM, Fingerle J, Reidy MA (1989a) Kinetics of cellular proliferation after arterial injury V. Role of acute distension in the induction of smooth muscle proliferation. Lab Invest 60: 360–364
Clowes AW, Clowes MM, Fingerle J, Reidy MA (1989b) Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 14 (Suppl 6): S12–S14
Crisp SJ (1995) The role of antiendothelial antibodies in the development of transplantation-associated coronary artery disease. Thesis, University of London, U.K.
Crisp SJ, Dunn MJ, Rose ML, Barbir M, Yacoub MH (1994) Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant 12: 81–92
Dressler FA, Miller LW (1992) Necropsy versus angiography: how accurate is angiography? J Heart Lung Transplant 11: 556–559
Dunn MJ, Rose ML (1993) Antibody mediated rejection following cardiac transplantation. In: Rose ML, Yacoub MH (eds) Immunology of heart and lung transplantation. Arnold, London, pp 200–215
Dunn MJ, Crisp S, Rose ML, Taylor PM, Yacoub MH (1992) Detection of anti-endothelial antibodies by Western blotting — positive correlation with coronary artery disease after cardiac transplantation. Lancet 339: 1566–1570
Emeson EE, Robertson AL (1988) T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 130: 369–376
Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW (1988) Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest 81: 21–31
Fyfe AI, Brownfield ED, Kobashigawa JA, Drinkwater DC, Laks H (1992) Rh incompatible cardiac transplantation is associated with increased early rejection and transplant atherosclerosis. Circulation 86 (Suppl 1): 628
Gao S-Z, Hunt SA, Schroeder JS, Alderman EL, Hill I, Stinson EB (1988) Retransplantation for severe accelerated coronary artery disease in the heart transplant recipients. Am J Cardiol 62: 876–881
Gao S-Z, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB (1989) Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation 80 (Suppl 3): 100–105
Gao S-Z, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB (1994) Does rapidity of development of transplant coronary artery disease portend a worse prognosis? J Heart Lung Transplant 13: 1119–1124
Gaudin PB, Rayburn BK, Hutchins GM, Kasper EM, Baughman KL, Goodman SN, Leeks LE, Baumgartner WA, Hruban RH (1994) Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Pathol 18: 338–346
Glagov S, Weinsenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371–1375
Glasgow E, Druger RF, Fuchs C, Levine EM, Giordano S, Schecter N (1994) Cloning of multiple forms of goldfish vimentin: Differential expression in CNS. J Neurochem 63: 470–481
Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA Jr, Jones KW, O’Connell JB (1989) Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8: 430–433
Hosenpud JD, Shipley GD, Wagner CR (1992) Cardiac allograft vasculopathy: Current concepts, recent developments, and future directions. J Heart Lung Transplant 11: 9–23
Hruban RH, Beschorner WE, Baumgartner WA (1990) Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 137: 872–882
Johnson DE, Alderman EL, Schroeder JS, Gao S-Z, Hunt S, DeCampli WM, Stinson E, Billingham M (1991) J Am Coll Cardiol 17: 449–457
Kataaha PK, Mortazavi-Milani SM, Russel G, Holborow EJ (1985) Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid artheritis and infection mononucleosis. Ann Rheum Dis 44: 446–449
Khaghani A, Yacoub M, McCloskey D, Awad J, Burden M, Fitzgerald M, Hawes R, Holmes J, Smith J, Banner N et al. (1989) The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporine and azathioprine. Transplant Proc 21: 799–800
Koo EWY, Gottlieb AI (1989) Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. Am J Pathol 134: 497–503
Kriett JM, Kaye MP (1990) The registry of the International Society for Heart Transplantation; Seventh official report — 1990. J Heart Transplant 9: 323–330
Kurki P, Virtanen I (1984) The detection of antibodies against cytoskeletal components. J Immunol Methods 67: 209–223
Kushwaha S, Maseri A, Mitchell A, Yacoub M (1991) Coronary reactivity in ergonovine: possible relationship to accelerated coronary arterial disease in cardiac transplant recipients. Eur Heart J 12: 524–525
Laden AMK (1972) The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts. Transplantation 13: 281–290
Le WD, Xie WJ, Glenn Smith R, Appel SH (1993) Vimentin cross reactive antibodies induce cell death in primary cultures of embryonic spinal cord. J Neuroimmunol 42: 15–22
Minick CR, Murphy GE (1973) Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. Am J Pathol 73: 265–292
Nikkari ST, Solakivi T, Sisto T, Jaakola O (1993) Antibodies to cytoskeletal protein in sera of patients with angiographically assessed coronary artery disease. Atherosclerosis 98: 11–16
Oni AA, Ray JA, Norman DJ, Hershberger RA, Wagner Cr, Hovaguimian H, Cobanoglu A, Hosenpud JD (1991) Cardiac allograft venopathy: a correlate to “accelerated transplant atherosclerosis”. J Heart Lung Transplant 10: 190 (abstract)
Page C, Rose M, Yacoub M, Pigott R (1992) Antigenic heterogeneity of vascular endothelium. Am J Pathol 141: 673–683
Pearson JD (1994) Autoantibodies to endothelial cells. In: Catravas JD (ed) Vascular endothelium. Plenum, New York
Pfeffer PF, Foerster A, Froysaker T, Simonsen S, Thorsby E (1988) HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated. Transplant Proc 20: 367–368
Pidwell DJ, Heller MJ, Gabler D, Orosz CG (1995) In vitro stimulation of human endothelial cells by sera from a subpopulation of high-percentage panel-reactive antibody patients. Transplantation 60: 563–569
Pinto FJ, Chenzbraun A, Gao S-Z, St Goar FG, Fischell T, Alderman EL (1993) Serial quantitative angiography and intracoronary ultrasound: do angiographic measurements match morphology? J Am Coll Cardiol 19: A192
Rose ML (1996) Role of antibody and indirect antigen presentation in transplant associated coronary artery vasculopathy. J Heart Lung Transplant 15: 342–349
Rose ML, Dunn MJ (1993) What causes accelerated coronary artery disease after cardiac transplantation? Prim Cardiol 19: 34–39
Rose ML, Coles MI, Griffin RJ, Pomerance A, Yacoub MH (1986) Expression of class I and class II major histocompatibility antigens in normal and transplanted heart. Transplantation 41: 776
Rose EA, Pepino P, Barr ML, Smith CR, Ratner AJ, Ho E, Berger C et al. (1992) Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Transplant 11: S120–S123
Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314: 488–500
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377
Russell PS, Chase CM, Winn HJ, Colvin RB (1994) Coronary atherosclerosis in transplanted mouse hearts II. Importance of humoral immunity. J Immunol 154: 5135–5141
Salomon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P (1991) Human coronary transplantation-associated arteriosclerosis: evidence of a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138: 791–798
Schoen FJ, Libby P (1991) Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med 1: 216–223
Schook LB, Wood N, Mohanakumar T (1987) Identification of human vascular endothelial cell/monocyte antigenic system using monoclonal antibodies. Transplantation 44: 412–416
Schroeder JS, Gao S-Z (1995) Accelerated graft coronary artery disease in heart-transplant recipients. Coron Artery Dis 6: 226–233
Shirotani M, Yui Y, Kawai C (1993) Restenosis after coronary angioplasty: pathogenesis of neointimal thickening initiated by endothelial loss. Endothelium 1: 5–22
Speiser B, Weihrauch D, Reiss CF, Schaper J (1992) The extracellular matrix in human cardiac tissue. Part II: Vimentin, laminin, and fibronectin. Cardioscience 3: 41–49
St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao S, Stinson EB, Popp RL (1992) Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of “angiographically silent” intimal thickening. Circulation 85: 979–987
Taylor PM, Rose ML, Yacoub MH (1993) Coronary artery immunogenicity: a comparison between explanted recipient or donor hearts and transplanted hearts. Transpl Immunol 1: 294–301
Taylor PM, Rose ML, Yacoub MH, Pigott R (1992) Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation 54: 451–457
Thorpe SJ (1990) Reactivity of a human monoclonal antibody against Rh D with intermediate filament protein vimentin. Br J Haematol 76: 116–120
Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty R, Trento A, Bahnson HT (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76: 827–834
Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML (1995) Characterization of endothelial antigens associated with transplant associated coronary artery disease. J Heart Lung Transplant 14: S188–S197
Wick G, Schett G, Amberger A, Kleindienst R, Xu Q (1995) Is atherosclerosis an immunologically mediated disease? Immunol Today 16: 27–33
Willems CH, Astyaldi GCB, De Groot G, Janssen MC, Gonsalvez MD, Zeijlemaker WP, Van Mourik JA, Van Aken WG (1982) Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res 139: 191–197
Xu Q, Oberhuber G, Gruschwitz M, Wick G (1990) Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen presentation in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 56: 344–359
Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufmann SH, Wick G (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12: 789–799
Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer G, Kiechl S, Stulnig T, Luef G, Wick G (1993) Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341: 255–259
Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G (1994) Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 75: 1078–1085
Yacoub M, Rose M (1994) Accelerated coronary artery sclerosis. Ann Cardiac Surg 7: 80–88
Zerbe T, Arena V, Kormos RL, Griffith BP, Hardesty RL, Duquesnoy RJ (1991) Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation. Transplantation 52: 485–490
Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith BP, Hardesty R, DuQuesnoy R (1992) Graft atherosclerosis: Effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 11: 104–110
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wheeler, C.H., Collins, A.D., Dunn, M.J., Crisp, S.J., Yacoub, M.H., Rose, M.L. (1997). Transplant Associated Coronary Artery Disease. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-60463-8_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61358-9
Online ISBN: 978-3-642-60463-8
eBook Packages: Springer Book Archive